European Neuroscience--Seventh Biennial FENS Forum
Affiliations
- PMID: 20799140
Item in Clipboard
European Neuroscience--Seventh Biennial FENS Forum
IDrugs.
2010 Sep.
Abstract
The European Neuroscience--Seventh Biennial FENS Forum, held in Amsterdam, included topics covering new therapeutic developments in the field of neuroscience. This conference report highlights selected presentations on sodium channel inhibitors, ionotropic glutamate receptor antagonists, serotonin receptor modulators, and novel therapies for depression, pain and stroke. Investigational drugs discussed include ST-1936 (Sigma-Tau Industrie Farmaceutiche Riunite SpA), LY-392098 (Eli Lilly & Co) and Lu-AA21004 (H Lundbeck A/S/Takeda Pharmaceutical Co Ltd).
Similar articles
-
Society for Neuroscience - 39th Annual Meeting. Part 2 - Novel therapies for neurodegenerative disorders and other CNS diseases.IDrugs. 2009 Dec;12(12):734-7. IDrugs. 2009. PMID: 19943211
-
Society for Neuroscience - 39th Annual Meeting. Part 1 - Novel therapies for the treatment of CNS disorders and pain.IDrugs. 2009 Dec;12(12):731-3. IDrugs. 2009. PMID: 19943210
-
Clinical trials in CNS--SMi's eighth annual conference.IDrugs. 2010 Feb;13(2):66-9. IDrugs. 2010. PMID: 20127552
-
Opportunities in systems biology to discover mechanisms and repurpose drugs for CNS diseases.Drug Discov Today. 2012 Nov;17(21-22):1208-16. doi: 10.1016/j.drudis.2012.06.015. Epub 2012 Jun 30. Drug Discov Today. 2012. PMID: 22750722 Review.
-
Gimatecan (sigma-tau industrie farmaceutiche riunite/novartis).IDrugs. 2005 Jul;8(7):578-88. IDrugs. 2005. PMID: 15973567 Review.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous